The Harvard Medical School Fellowship Program in Transfusion Medicine is an ACGME accredited program which draws on the facilities of the MGH, Brigham and Women’s Hospital, Children’s Hospital Boston, Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center.
In addition, the program maintains strong ties with the Center for Blood Research. The usual period of clinical fellowship is one year; however, the program offers suitably qualified fellows the opportunity to pursue research relevant to transfusion medicine supported by a NIH training grant for an additional one or two years.
Trainees spend 4 months at their base hospital (Massachusetts General Hospital, the Brigham and Women’s Hospital, or the Beth Israel Deaconess Medical Center) and an additional 2 months at one of the partner hospitals. Fellows rotating at the Brigham and Women’s Hospital also train at the Dana-Farber Cancer Institute and Children’s Hospital Boston. An additional 4 weeks is spent at the Cell Manipulation Core Facility of the Dana-Farber Cancer Institute. The remaining 3 months are spent in elective rotations, which are chosen once the trainee has received a thorough grounding in transfusion medicine and begun to formulate specific career goals.
Clinical and basic research are conducted throughout the program. Fellows are encouraged to develop a research focus during their first year which can be pursued for an additional one or two years. Fellows have the opportunity to attend varied clinical and research conferences and are required to teach in the training programs offered to residents, students and post-graduates.
Additional information about the program is available on the website: www.harvardtransfusion.org
Types and Numbers of Appointments
There are 3 funded clinical fellowship positions and 8 funded research fellowship positions.
The combined facilities of the Harvard Joint Program comprise 2,478 hospital beds supporting a comprehensive array of general and specialized services including transplantation, Level I Pediatric and Adult Trauma and Burn Units, multiple intensive care units, and centers for Sickle Cell Disease and Hemophilia. The facilities collect approximately 38,000 donations of whole blood and platelets and transfuse approximately 190,000 components annually. The combined facilities of the Harvard Joint Program offer an unparalleled array of services, which encompass all aspects of Transfusion Medicine.
Applicants must be Board-certified or eligible for certification in Clinical Pathology, adult or pediatric Hematology/Oncology or Anesthesia and, if a graduate of an international medical school, have a valid ECFMG certificate and visa and a full Massachusetts medical license prior to starting the fellowship.
Massachusetts General Hospital
Beth Israel-Deaconess Medical Center
Richard Haspel, MD, PhD
Kerry L. O'Brien, MD
J. Ryan Pena, MD, PhD
Lynne Uhl, MD
Brigham and Women's Hospital
Li Chai, MD
Richard Kaufman, MD
William Savage, MD, PhD
Children's Hospital, Boston
John Manis, MD
Steven Sloan, MD, PhD
Leslie Silberstein, MD
Dana-Farber Cancer Institute
Jerome Ritz, MD
Applications should be submitted by December 31 (18 months prior to start date; Fellowships usually commence on July 1).
Instructions for application, an application form and contact information are available on the program website: www.harvardtransfusion.org
Inquiries about the program, and particularly the MGH-based rotations, should be addressed to:
MGH Program Director
Christopher P. Stowell, MD, PhD
Massachusetts General Hospital
55 Fruit Street, Gray/Jackson-148
Boston, MA 02114